Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

Biocon cancels plans to market Novo Nordisk generics in China due to local competition, focusing on other markets.

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Wall Street is getting worried about United Airlines. Yes, it's mostly about Newark airport. United has a major hub at Newark Liberty International Airport, and Wall Street wonders just how much the ...

If you’ve been waiting for the chance for weight loss injections to drop in price, there are more options turning up to ...

A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss ...

Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move ...

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

It would behoove more Americans to learn how consistent seafood consumption has strong potential to ward off coronary disease ...

Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...